JSPR Q2 2022 Earnings — Jasper Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

JSPRJasper Therapeutics, Inc.

$22M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$12M

Net Income

-$10M

EPS (Diluted)

$-2.86

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$10M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$70M

Total Liabilities

$12M

Stockholders' Equity

$59M

Cash & Equivalents

$61M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$12M	-$8M	-42.1%
Net Income	-$10M	-$8M	-23.7%